Bank of New York Mellon Corp Invests $57.45 Million in Cabot Corporation $CBT

Key Points

• Bank of New York Mellon acquired 632,518 Cabot shares valued at approximately $57.45 million, while institutional investors collectively own 93.18% of the company.
• Cabot reported quarterly EPS of $1.67, slightly exceeding estimates, and revenue of $982 million, up 6.4% year over year. The company guided to fiscal 2026 EPS of $6.15–$6.45.
• Analysts maintain a consensus “Hold” rating with an $89 target price, compared with shares opening at $84.68. Cabot also declared a quarterly dividend of $0.4725, representing a 2.2% annualized yield.

Bank of New York Mellon Corp bought a new position in Cabot Corporation (NYSE:CBT - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 632,518 shares of the specialty chemicals company's stock, valued at approximately $57,445,000. Bank of New York Mellon Corp owned 1.23% of Cabot at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of Cabot in the 4th quarter worth about $49,662,000. AQR Capital Management LLC grew its holdings in shares of Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company's stock worth $65,096,000 after purchasing an additional 478,702 shares during the period. UBS Group AG increased its position in Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company's stock worth $45,136,000 after purchasing an additional 386,514 shares in the last quarter. Pacer Advisors Inc. raised its holdings in Cabot by 3,165.7% in the fourth quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company's stock valued at $15,195,000 after buying an additional 222,232 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Cabot during the fourth quarter valued at approximately $8,785,000. Hedge funds and other institutional investors own 93.18% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CBT. UBS Group dropped their price objective on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research report on Wednesday, August 5th. Truist Financial set a $100.00 target price on shares of Cabot in a report on Wednesday, August 5th. Wall Street Zen raised shares of Cabot from a "hold" rating to a "buy" rating in a research report on Sunday, August 9th. Weiss Ratings reissued a "hold (c)" rating on shares of Cabot in a research report on Friday, August 21st. Finally, JPMorgan Chase & Co. boosted their price objective on Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research note on Friday, August 7th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $89.00.

Cabot Stock Up 1.2%

Shares of Cabot stock opened at $84.68 on Thursday. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $94.53. The company has a market capitalization of $4.37 billion, a PE ratio of 23.85, a P/E/G ratio of 10.98 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The business has a 50-day moving average of $87.91 and a 200-day moving average of $81.11.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping the consensus estimate of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The business had revenue of $982.00 million for the quarter, compared to analysts' expectations of $943.16 million. During the same quarter in the previous year, the firm posted $1.90 earnings per share. The company's revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities analysts forecast that Cabot Corporation will post 6.35 EPS for the current fiscal year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Friday, August 28th. Cabot's payout ratio is 53.24%.

Insider Activity

In related news, CEO Sean D. Keohane sold 2,779 shares of the company's stock in a transaction on Monday, August 24th. The shares were sold at an average price of $85.50, for a total value of $237,604.50. Following the sale, the chief executive officer directly owned 288,873 shares of the company's stock, valued at $24,698,641.50. This represents a 0.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.08% of the company's stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source